The GlutenTox® ELISA Rapid G12 test kit offers a systematic method for evaluating gluten content from wheat, barley and rye in food samples. Its precision and reliability have earned it the AOAC RI Performance Tested MethodsSM certification. The kit aligned with AOAC’s exacting standards, confirming its capability to accurately detect and quantify wheat gluten in a variety of […]

LONDON and MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) and Cizzle Biotechnology Holdings plc, the UK-based diagnostics developer, are pleased to announce recent progress evaluating specific monoclonal antibodies for Cizzle’s CIZ1B cancer biomarker. Cizzle has successfully completed an evaluation programme aimed at assessing the feasibility of using the Simple Western platform from ProteinSimple (a Bio-Techne Brand) for high […]

DNA Link will bring the power of the largest proteomics platform available to their biomarker discovery and drug development work BOULDER, Colo. and SEOUL, Korea — SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with DNA Link, an innovator in personalized and precision medicine, to offer the 7,000-plex SomaScan® platform to […]

New AI-powered TIMSquant™ software for CCS-enabled, label-free quantification scalable to thousands of samples Early midia-PASEF® access for immunopeptidomics and PTMs on ultra-sensitive timsTOF Ultra for DDA-like precursor traceability in dia-PASEF Affordable, high-throughput ~3,500 PG plasma proteomics on timsTOF HT with PreOmics ENRICH kit using Biognosys Spectronaut® 18 directDIA+™ software New PepSep™ ULTRA XL and MAX HT nano-LC columns for DDA […]

Fully quantitative bulk and comprehensive single cell proteomics are now both available on the IsoSpark platform EMERYVILLE, Calif. — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced the launch of Meteor™ chips on the IsoSpark™ platform, providing a significant advancement in high throughput, quantitative, fully automated, multiplexed bulk proteomics. ™ The Meteor chip solution enables researchers […]

Empowering researchers to spatially profile more than 500 proteins simultaneously in FFPE tissue using abcam’s IHC-validated immuno-oncology antibody portfolio Seattle — NanoString Technologies, a leading provider of life science tools for discovery and translational research, announced today the launch of the latest assay for the GeoMx® Digital Spatial Profiler (DSP). The GeoMx IO Proteome Atlas (IPA) is […]

UPPSALA, Sweden — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the collaboration with Eurofins Genomics to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology. The Olink platform represents the cutting edge in proteomics technology, delivering exceptional sensitivity and specificity for protein biomarker […]

Caption: (Left) Pyrophosphatase (inorganic), HQ; (Right) T7 RNA Polymerase, HQ. Saint-Germain-en-Laye, France – Takara Bio Europe (TBE) announced today the launch of new High Quality (HQ) grade mRNA production enzymes “T7 RNA polymerase, HQ” and “Pyrophosphatase (inorganic), HQ” suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing. HQ grade enzymes have features […]

AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development, its regulation by HER2 signalling, and its potential as a therapeutic target. Characterized by the overexpression of the Human Epidermal growth factor Receptor 2 (HER2) – HER2+ breast cancer is a highly aggressive disease […]

FARMINGDALE, NY  —  Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Operating Officer, Kara Cannon, assuming the role of interim CEO. “We thank Hamid for the commitment he […]